BEVERLY HILLS, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)TOWER CANCER RESEARCH FOUNDATION, founded in 1996, is a community nonprofit in the Medical Research sector that reported $3.1M in total revenue in fiscal year 2024. Revenue surged 24% from the prior year, signaling strong growth momentum. Expenses of $3.6M exceeded revenue, resulting in a 16% operating deficit.
THROUGH LOCAL INVESTMENTS, WE ADVANCE GROUNDBREAKING CANCER RESEARCH AND PROFOUNDLY SUPPORT PEOPLE AFFECTED BY THE DISEASE TO CREATE OUTSIZED IMPACT IN SOUTHERN CALIFORNIA AND BEYOND.
IN 2023, TOWER FUNDED FOUR NEW CAREER DEVELOPMENT RESEARCH GRANTS FOR FOUR PROMISING YOUNG PHYSICIAN SCIENTISTS LOCATED AT UCLA, UCI AND UCSD. RESEARCH AREAS FOCUS ON INNOVATIVE THERAPIES SUCH AS...
IN 2023, TOWER FUNDED FOUR NEW CAREER DEVELOPMENT RESEARCH GRANTS FOR FOUR PROMISING YOUNG PHYSICIAN SCIENTISTS LOCATED AT UCLA, UCI AND UCSD. RESEARCH AREAS FOCUS ON INNOVATIVE THERAPIES SUCH AS: THE USE OF PH TO TARGET GLIOBLASTOMA CELLS IN HOPES TO IMPROVE TREATMENT FOR THIS DEADLY DISEASE; USING A MODEL OF SKIN CANCER, A NEW TOOL TO TRACK CANCER CELLS IN THEIR NATURAL HABITAT TO FIND HOW LYMPHATIC VESSELS SHIELD CANCER CELLS AND AID THEIR SPREAD TO OTHER PARTS OF THE BODY; TARGETING LIVER-METASTATIC PANCREATIC CANCER BY IDENTIFYING WEAKNESSES THAT CAN BE EXPLOITED TO SLOW THE GROWTH OF TUMORS IN THE LIVER OR POSSIBLY PREVENT THE ESTABLISHMENT OF METASTASIS FROM HAPPENING IN PANCREATIC CANCER; STEM CELL REPROGRAMMING OF ANTI-TUMOR T CELLS TO MAKE TIL THERAPY A MORE EFFECTIVE TREATMENT. IN ADDITION, TOWER CONTINUED FUNDING MUL-TI-YEAR SENIOR INVESTIGATOR GRANTS. TOTAL SCIENTIFIC GRANT EXPENDITURES IN 2023 TOPPED $700,000. INVESTING IN NOVEL IDEAS OF YOUNG INVESTIGATORS AND EXPERIENCED SENIOR INVESTIGATORS ALLOWS US TO LEVERAGE OUR DONOR DOLLARS TO HAVE MAXIMUM IMPACT. IN 2023 ALONE, TCRF RESEARCHERS REPORTED NEARLY $3M IN FOLLOW-ON FUNDING, DOZENS OF GRANTS, PUBLICATIONS ACADEMIC AWARDS, TWO CLINICAL TRIALS, AND SO MUCH MORE.OUR CLINICALLY-GROUNDED SURVIVORSHIP SUPPORT PROGRAMS, HOSTED BY MAGNOLIA HOUSE, ALIGN WITH THE CHALLENG-ES FACED BY PATIENTS, SURVIVORS, AND THE WHOLE CANCER COMMUNITY. WE PROVIDE INTEGRATIVE HEALTH AND WELL-NESS SUPPORT AND EDUCATION, THROUGH FREE FITNESS, THERAPEUTIC, AND HOLISTIC CLASSES, THAT EMPOWERPEOPLE TO DEVELOP A PHYSICAL AND EMOTIONAL TOOLKIT TO MEET THE CHALLENGES OF CANCER FROM DIAGNOSIS TO SURVIVORSHIP. IN 2023, TOWER INVESTED OVER $500,000 IN SURVIVORSHIP PROGRAMS. IN 2013, MAGNOLIA HOUSE SURVIVORSHIP SUPPORT PROGRAM OFFERED 20 CLASSES AND HAD 500 VISITS IN THE FIRST YEAR. IN 2023, MAGNOLIA HOUSE OFFERED OVER 1500 CLASSES/SERVICES AND RECEIVED OVER 20,000 PARTICIPANT VISITS. IN RESPONSE TO COVID19, WE CONTINUED OFFERING CLASSES ONLINE VIA ZOOM WHICH HAS EXPANDED THE DEMOGRAPHICS IN WHICH WE SERVICE AND ENABLED US TO INCREASE OUR CLASS CAPACITIES. WE ADDED OUTDOOR PROGRAMMING AT LOCAL PARKS WHICH HAVE BEEN WELL RECEIVED. EVEN WITH AN INCREASE IN CLASS CAPACITIES, MANY OF OUR CLASSES HAD A WAIT LIST WHICH HIGHLIGHTS BOTH THE QUALITY IN THE PROGRAMS WE OFFER AND THE VOID THAT EXISTS, ESPECIALLY WITH THE ISO-LATION MANY CANCER PATIENTS EXPERIENCE. PARTICIPANTS VIEW MAGNOLIA HOUSE SURVIVORSHIP SUPPORT PROGRAM AS A LIFELINE THAT PROVIDES NOT ONLY ENHANCED QUALITY OF LIFE BUT A COMMUNITY OF FRIENDSHIP, ENCOURAGEMENT, AND COMFORT AS WELL. ONE EXAMPLE THAT REFLECTS THE IMPACT OF MAGNOLIA HOUSE, IS THE SURVIVOR 2 THRIVER PEER TO PEER FUNDRAISING CAMPAIGN WE LAUNCHED IN THE SUMMER OF 2023. OUR GOAL WAS TO RAISE $5,000. MAGNOLIA HOUSE PARTICIPANTS RAISED $30,000 THROUGH THIS CAMPAIGN, HIGHLIGHTING THE DEPTH OF COMMUNITY AND IMPACT OF THE MAGNOLIA HOUSE PROGRAM.TOWER'S COMMUNITY PARTNERSHIP GRANT REVIEW COMMITTEE IS COMPOSED OF EXPERT VOLUNTEERS WHO REVIEW APPLICATIONS IN DEPTH AND THEN MEET TO DISCUSS GRANT APPLICATIONS FROM CANCER SUPPORT ORGANIZATIONS ACROSS SOUTHERN CALIFORNIA. IN 2023, WE FUNDED $200,000 IN COMMUNITY PARTNER GRANTS AND CONTINUED TO REFINE OUR REVIEW PROCESS WITH A NEW GRANT MANAGEMENT SYSTEM, NEW AND EXPERIENCED PEER GRANT REVIEWERS, AND A NEEDS ASSESSMENT TO REFLECT A MORE TARGETED FOCUS ON FUNDING ORGANIZATIONS THAT SUPPORT UNDERSERVED AND UNDER RESOURCED COMMUNITIES ALLOWING US TO EXTEND OUR SUPPORT TO THOSE MOST IN NEED OF CARE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $3,146,877 | $2,539,108 | +0.2% |
| Expenses | $3,636,819 | $3,174,666 | +0.1% |
| Net Income | $-489,942 | $-635,558 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| NANCY ROSENFELT | CHAIRMAN OF THE BOARD | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| LARRY ROSENSTEIN | VICE CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DONNA ROSEN | PAST CHAIRMAN OF THE BOARD | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| NANCY MISHKIN | PAST CHAIRMAN OF THE BOARD | 2.00 |
Director
|
$0 | $0 | $0 |
| DAVID SPINGARN | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JEANNE SCHNITZER MARKS | SECRETARY | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| KELLY PRATHER | MAGNOLIA COUNCIL PRESIDENT | 2.00 |
Director
|
$0 | $0 | $0 |
| JONATHAN LAYNE | DEVELOPMENT COMMITTEE CHAI | 2.00 |
Director
|
$0 | $0 | $0 |
| SHELLEY WARSAVSKY | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| ELIZABETH DRUCKER | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| LINDA LEVENSON DELSACK | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| BETTY HAAGEN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| RANDY KATZ | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| BETH GOREN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| SUSAN KREVOY PHD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| FRANKIE SHOLEM | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| BARRY ROSENBLOOM MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JOHN CARPTEN PHD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| GEORGE RADDA | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| HOORA SADLER | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JULIE SHAMES | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| KATHY SCOTT | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| PEGGY MILES | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| CHRISTOPHER CLINTON CONWAY | EXECUTIVE DIRECTOR | 40.00 |
Officer
Director
|
$280,777 | $14,810 | $295,587 |
| LINDA DAVID | EXECUTIVE DIRECTOR (THRU 1/5) | 40.00 |
Officer
Director
|
$9,050 | $0 | $9,050 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $3,146,877 | $3,636,819 | $3,237,640 | $-489,942 |
| 2023 | $2,539,108 | $3,174,666 | $3,927,785 | $-635,558 |
| 2022 | $2,865,725 | $3,160,741 | $4,621,629 | $-295,016 |
| 2021 | $2,998,998 | $3,480,662 | $3,869,425 | $-481,664 |
| 2020 | $2,672,021 | $2,863,801 | $3,952,393 | $-191,780 |
| 2019 | $3,739,380 | $2,598,491 | $3,940,038 | $1,140,889 |
| 2018 | $3,418,112 | $3,668,871 | $3,316,830 | $-250,759 |
Compare TOWER CANCER RESEARCH FOUNDATION with other nonprofits in California and across the country.